A Phase I Clinical Study of CD70-targeting CAR-T Therapy in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Latest Information Update: 23 Aug 2023
At a glance
- Drugs Anti-CD70 chimeric antigen receptor T cell therapy-Chongqing Precision Biotech (Primary) ; Anti-CD70 chimeric antigen receptor T cell therapy-Chongqing Precision Biotech (Primary) ; Cyclophosphamide; Fludarabine
- Indications Solid tumours
- Focus Adverse reactions
- 30 Aug 2022 New trial record